Eliem Therapeutics, Inc. Business Finance Contracts & Agreements
9 Contracts & Agreements
- Contribution Agreements (1 contract)
- Investor Rights Agreements (1)
- Joinder Agreements (1)
- Purchase Agreements (2)
- Registration Rights Agreements (1)
- Stock Agreements (2)
- Underwriting Agreements (1)
- Asset Purchase Agreement, dated as of January 11, 2024, by and between Tenet Medicines, Inc., Acelyrin, Inc. and WH2, LLC (Filed With SEC on June 27, 2024)
- Registration Rights Agreement, dated April 10, 2024, by and among Eliem Therapeutics, Inc. and the persons party thereto (Filed With SEC on April 11, 2024)
- Securities Purchase Agreement, dated April 10, 2024, by and among Eliem Therapeutics, Inc. and the persons party thereto (Filed With SEC on April 11, 2024)
- Form of Tenet Support and Joinder Agreement (Filed With SEC on April 11, 2024)
- 2021 Employee Stock Purchase Plan (Filed With SEC on August 2, 2021)
- Form of common stock certificate of the Registrant (Filed With SEC on August 2, 2021)
- Form of Underwriting Agreement (Filed With SEC on August 2, 2021)
- Amended and Restated Investor Rights Agreement, dated May 21, 2021, by and among the Registrant and the investors listed on Schedule A thereto (Filed With SEC on July 16, 2021)
- Asset Contribution Agreement, dated February 4, 2019, by and between the Registrant and Carnot, LLC (Filed With SEC on July 16, 2021)